Advertisement
UK markets open in 2 hours 1 minute
  • NIKKEI 225

    38,220.71
    -53.34 (-0.14%)
     
  • HANG SENG

    18,155.28
    +392.25 (+2.21%)
     
  • CRUDE OIL

    79.56
    +0.56 (+0.71%)
     
  • GOLD FUTURES

    2,328.30
    +17.30 (+0.75%)
     
  • DOW

    37,903.29
    +87.37 (+0.23%)
     
  • Bitcoin GBP

    45,692.32
    -2,343.61 (-4.88%)
     
  • CMC Crypto 200

    1,262.02
    -77.05 (-5.75%)
     
  • NASDAQ Composite

    15,605.48
    -52.34 (-0.33%)
     
  • UK FTSE All Share

    4,418.60
    -11.65 (-0.26%)
     

Director Daren Shaw Sells Shares of Ensign Group Inc (ENSG)

Director Daren Shaw has sold 4,463 shares of Ensign Group Inc (NASDAQ:ENSG) on April 15, 2024, according to a recent SEC Filing. Ensign Group Inc is a healthcare services company that provides skilled nursing, rehabilitative care services, home health and hospice care, and assisted living services.Over the past year, the insider has sold a total of 24,463 shares of Ensign Group Inc and has not made any purchases of the stock. The company's insider transaction history indicates a total of 19 insider sells and no insider buys over the same timeframe.Shares of Ensign Group Inc were trading at $118.96 on the day of the insider's recent sale, giving the company a market cap of $6.707 billion. The price-earnings ratio stands at 32.28, which is above both the industry median of 24.955 and the company's historical median price-earnings ratio.The stock's price-to-GF-Value ratio is 1, with a GuruFocus Value of $118.58, indicating that Ensign Group Inc is Fairly Valued based on its GF Value. The GF Value is calculated considering historical trading multiples, a GuruFocus adjustment factor, and future business performance estimates from Morningstar analysts.

Director Daren Shaw Sells Shares of Ensign Group Inc (ENSG)
Director Daren Shaw Sells Shares of Ensign Group Inc (ENSG)
Director Daren Shaw Sells Shares of Ensign Group Inc (ENSG)
Director Daren Shaw Sells Shares of Ensign Group Inc (ENSG)
ADVERTISEMENT

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

This article first appeared on GuruFocus.